Literature DB >> 16527115

[Calculation of the number of terminally ill patients through their use of opioid analgesics and tumor mortality].

E Escortell-Mayor1, O Larrubia-Muñoz, D Troncoso-Viejo, R Martínez-Martínez, A López-Romero, C de Miguel-Sánchez.   

Abstract

OBJECTIVE: To find the number of patients in terminal care in Madrid Health District 3.
DESIGN: Ecological, descriptive study.
SETTING: Eleven Health Districts. Madrid, Spain, 2002. MAIN MEASUREMENTS: Two models were used to calculate the number of patients in terminal care and were compared with data from the Primary Care Service Portfolio. Model A: consumption of morphine and fentanyl. The number of defined daily doses (DDD) of these active principles and the DDD per 1000 inhabitants and day (DID) were calculated. Prescription details: prescriptions charged to Social Security from registered doctors in Madrid (primary care and specialists). Model B: tumor mortality, i.e. the number of deaths due to tumors in the year 2000, published in 2004.
RESULTS: The number of terminal patients calculated by the 2 models in 7 of the 11 Health Districts and in the Community of Madrid is higher than in the Primary Care Service Portfolio. In the Community of Madrid, morphine and fentanyl are prescribed basically in primary care (96%). There was an important jump in fentanyl prescription from 2001 to 2002, due to the main fentanyl prescribed being transdermal.
CONCLUSIONS: There are differences between the models in calculation of terminal patients. Moreover, the models offer heterogeneous results between health districts. Fentanyl consumption has become greater than morphine use in Madrid. The registers of terminal patients and/or their recruitment need to be improved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527115      PMCID: PMC7668897          DOI: 10.1157/13084486

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  9 in total

1.  [Pharmaceutical care, studies of the use of medications and other].

Authors:  A Iñesta García
Journal:  Rev Esp Salud Publica       Date:  2001 Jul-Aug

2.  [Impact of the commercialisation of transdermic fentanyl on the home care of terminal cancer patients].

Authors:  M Fusté I Gamisans; X Busquet Duran
Journal:  Aten Primaria       Date:  2002-03-31       Impact factor: 1.137

3.  [Use of opiate analgesics in terminal cancer patients during the last two months of life].

Authors:  D G de Diego Sierra; M A Monescillo Rodríguez; I Martínez González; A M Pérez-Serrano Ruiz; R Caballero De La Calle
Journal:  Aten Primaria       Date:  2002-05-31       Impact factor: 1.137

4.  [The estimation of prevalence of Parkinson disease in Navarra. An epidemiological study of the consumption of anti-parkinsonian drugs].

Authors:  M T Artázcoz Sanz; J J Viñes Rueda
Journal:  Rev Esp Salud Publica       Date:  1995 Nov-Dec

5.  [How we use opioid drugs on patients with neoplasms].

Authors:  A Rispau Falgàs; M Soler Vila; I García Bayo; A Vallés Plasencia; R Saladich Puig; V Martínez Alemany
Journal:  Aten Primaria       Date:  1999-11-30       Impact factor: 1.137

6.  [Hypertensive patients treated in Spain, 1990-1993].

Authors:  A J García Ruiz; I García Ruiz; P Aranda Lara; A C Montesinos; F Martos Crespo; F Sánchez de la Cuesta
Journal:  Rev Esp Salud Publica       Date:  1997 Jan-Feb

7.  [Estimate of type I bipolar disorder prevalence (1996-1998)].

Authors:  J J Criado-Alvarez; J A Domper Tornil; G de la Rosa Rodríguez
Journal:  Rev Esp Salud Publica       Date:  2000 Mar-Apr

8.  [Evaluation of primary care treatment of oncology patients with opiates].

Authors:  R Sánchez González; O Rupérez Cordero; A Guerra Merino; L García Domínguez; E Cidoncha; C Marcello
Journal:  Aten Primaria       Date:  1995-06-30       Impact factor: 1.137

9.  Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey.

Authors:  Chiara Salvato; Gianfranco Aretini; Donatella Serraglia; Gianni Terrazzani; Patrizia Debetto; Pietro Giusti; Alessandro Chinellato
Journal:  Pharmacol Res       Date:  2003-07       Impact factor: 7.658

  9 in total
  1 in total

1.  Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine.

Authors:  Javier Garcia del Pozo; Alfonso Carvajal; Jose Maria Viloria; Alfonso Velasco; Victorina Garcia del Pozo
Journal:  Eur J Clin Pharmacol       Date:  2007-12-20       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.